At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71%…
Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses…
The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people…
DENVER, CO / ACCESSWIRE / June 15, 2024 / Each year over 120,000 Coloradans are affected by debilitating chronic wounds,…
REYKJAVIK, Iceland, June 15, 2024 /PRNewswire/ -- In a recent display of global baking talent, the 52nd UIBC International Competition for…
– ENERGIZE is the First Study to Demonstrate Efficacy of an Oral Treatment for Non-Transfusion-Dependent Alpha- and Beta-Thalassemia – – Additional…
MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), reports that it…
Entrepreneur Of The Year celebrates ambitious entrepreneurs who are shaping the future DALLAS, June 14, 2024 /PRNewswire/ -- Ernst &…
Marcroft Medical proudly announces its launch as a trusted distributor of high-quality medical equipment, offering a comprehensive range of products…
NEW YORK, June 14, 2024 /PRNewswire/ -- The global smart weight, body composition, and BMI scales market size is estimated to grow by…